FUNDAMENTALS
EdgeFII/DII
AGARWALEYEDR Agarwals Health Care L
₹553.50+0.07%
Terminal
  • Overview
  • Price
  • Ratios
  • About
  • P&L
  • Balance
  • Cash flow
  • Holders
  • Actions
  • Peers
  • News
AGARWALEYENSE · EquityHealthcare

DR Agarwals Health Care L

ISIN
INE943P01029
Instrument key
NSE_EQ|INE943P01029
Open in terminal Fundamentals cached for 6 hours
Last traded price
₹553.50+0.40 · +0.07%
Day rangecircuit ₹442.75 – ₹664.05
547.55
557.90

as of 21/11/2026, 2:55:00 pm

Open
₹549.60
Day high
₹557.90
Day low
₹547.55
Prev. close
₹553.10
Volume
86.1K
VWAP
₹554.30

On this page

Company

  • Overview
  • Price chart
  • Key ratios
  • About

Statements

  • Profit & loss
  • Balance sheet
  • Cash flow

Ownership

  • Shareholding
  • Corporate actions
  • Peers

Market

  • News

02/Price history

Price chart

1 week · 15-minute candles. Hover the chart for the OHLC of any candle; the table below holds the same data row by row.

1D1W1M
6M
1Y
5Y
MAX
Change · 1W
+0.98%
548.15 → 553.50
Period high
₹558.50
19/11/2026
Period low
₹535.00
18/11/2026
From high
-0.90%
+3.46% from low
Avg volume
4.7K
5.89 L total
Candles
125
59 up / 63 down
20 Nov 2026O 552.95H 554.80L 552.00C 553.50Vol 6.6K
SMA 20SMA 50Averages need 50 candles before they begin
Candle data125 rows of open, high, low, close and volumeShowHide
20 Nov 2026552.95554.80552.00553.50+0.10%2.806.6K
20 Nov 2026553.20554.45552.50552.95-0.05%1.956.6K
20 Nov 2026553.15553.55551.95553.10-0.01%1.601.7K
20 Nov 2026552.50554.20552.50553.25+0.14%1.702.2K
20 Nov 2026551.75552.85551.50552.40+0.12%1.351.5K
20 Nov 2026550.60552.35550.30551.75+0.21%2.052.7K
20 Nov 2026549.80552.45549.45550.60+0.15%3.004.1K
20 Nov 2026552.25552.90548.60549.65-0.47%4.304.9K
20 Nov 2026552.60553.15552.10552.25-0.06%1.053.4K
20 Nov 2026552.75553.25552.50552.60-0.03%0.751.7K

Historical price and volume data · Showing 1–10 of 125

1 / 13

03/Valuation & returns

Key ratios vs sector

Company value benchmarked against the sector median. The ratio set is sector specific — banks report NIM, CASA and Net NPA instead of EV/EBITDA.

P/E

Price ÷ earnings per share

85.46
Company
85.46
Sector
39.99

Worse than sector by 114%

P/B

Price ÷ book value per share

7.85
Company
7.85
Sector
4.0

Worse than sector by 96%

ROA

Net income ÷ total assets

4.88%
Company
4.88%
Sector
10.51%

Worse than sector by 54%

ROE

Net income ÷ shareholders' equity

8.04%
Company
8.04%
Sector
17.51%

Worse than sector by 54%

ROCE

EBIT ÷ capital employed

10.12%
Company
10.12%
Sector
18.73%

Worse than sector by 46%

Quick Ratio

Liquid assets ÷ current liabilities

1.04
Company
1.04
Sector
2.72

Worse than sector by 62%

EV/EBITDA

Enterprise value ÷ EBITDA

26.89
Company
26.89
Sector
14.77

Worse than sector by 82%

04/Business

About the company

Sector: Healthcare

Dr. Agarwal's Health Care Ltd is an India-based company, which operates as a health care institution. The Company is engaged in running, owning and managing eye care hospitals, optical, pharmacies, etc. and related services. It provides a comprehensive range of eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sells optical, contact lenses and accessories, and eye-care related pharmaceutical products. Its services include surgeries and consultations, diagnoses and non-surgical treatments. Its surgery services include cataract surgery, refractive surgery, and other surgery. Its consultations, diagnoses and non-surgical treatments offer doctor consultation services, diagnostic services for eye disorders along with non-surgical treatments, including retinal laser therapy and dry eye treatment. It provides a range of glasses, lenses, contact lenses and frames at its facilities.

Sector market cap (INR)
₹17,561 Cr

reported in crore

Sector market cap (USD)
$1.95B

reported in billion

Market capitalisation is reported at the sector-constituent level, not the standalone company level.

05/Profit & loss

Consolidated income statement

Quarterly figures in ₹ crore. Growth marked reported is provided; margins are derived.

YearlyQuarterly
ConsolidatedStandalone
Revenue · Sep 2026
₹665 Cr
+7.22% vs Jun 2026
Net profit · Sep 2026
₹57 Cr
+3.33% vs Jun 2026
Operating margin
12.0%
was 12.1%
Revenue CAGR · 4p
7.2%
profit 9.2% · op 7.2%
Filed order
Revenue665620577540
Revenue growthreported7.2%7.6%6.7%—
Operating profit80757765
Operating profit growthreported6.3%-1.9%18.3%—
Operating marginderived12.0%12.1%13.3%12.0%
Net profit57555044
Net profit growthreported3.3%10.1%14.5%—
Net marginderived8.5%8.9%8.7%8.1%
EPS — basic₹/share, annual——4.21—

Figures in ₹ crore. Margin rows are computed from the reported values.

06/Balance sheet

Consolidated balance sheet

Only annual balance sheets are available — the quarterly filter does not apply here. Figures in ₹ crore; net worth is assets minus liabilities.

ConsolidatedStandalone
Total assets · Mar 2026
₹3,942 Cr
+7.36% YoY
Total liabilities
₹1,822 Cr
Net worth
₹2,120 Cr
Liabilities ÷ assets
46.2%
lower means a lighter balance sheet
Filed order
Total assets3,9423,6722,7531,825
Total liabilities1,8221,7451,3731,166
Net worthderived2,1201,9271,380659
Liabilities ÷ assetsderived46.2%47.5%49.9%63.9%
Asset growthderived7.4%33.4%50.8%—

Figures in ₹ crore. Stacked chart height equals total assets.

Full annual line itemsNon-current & current assets, liabilities, equity capitalShowHide
Filed order
Non-Current Assets3,3692,8831,9941,515
Current Assets573789759310
Total Assets3,9423,6722,7531,825
Current Liabilities461478400301
Net Current Asset1113113599
Non-Current Liabilities1,3611,267974865
Equity Capital2,1201,9271,380659
Total Equity & Liabilities3,9423,6722,7531,825

Figures in ₹ crore unless the line item is per-share.

07/Cash flow

Consolidated cash flow

Annual only, in ₹ crore. Negative values are outflows, so healthy companies usually show positive operating and negative investing cash flow.

ConsolidatedStandalone
Operating · Mar 2026
₹519 Cr
+45.32% YoY
Investing
-₹308 Cr
Financing
-₹220 Cr
Free cash flow
₹211 Cr
operating + investing
Filed order
Operating activities519357346233
Operating changereported45.3%3.2%48.4%—
Investing activities-308-750-914-509
Investing changereported58.9%17.9%-79.5%—
Financing activities-220382553303
Financing changereported-157.7%-30.9%82.2%—
Net cash flowderived-10-11-1527
Free cash flowoperating + investing211-393-568-276

Figures in ₹ crore.

Full annual line itemsProfit before tax through closing cash balanceShowHide
Filed order
Profit before tax24916014184
Income before WC changes622491373281
Change in Assets-89-133-48-31
Change in Liabilities41355219
Change in WC-48-985-13
Cash flow from Operations519357346233
Cash flow from Investing-308-750-914-509
Cash flow from Financing-220382553303
Total Cash Flow-10-11-1527
Cash (Start of the year)100112127100
Cash (End of the year)91100112127

Figures in ₹ crore unless the line item is per-share.

08/Ownership

Shareholding pattern

Percentage of total shares by holder category across the last 4 reported quarters. Sort any quarter column to rank holders by size.

Promoters
32.33%
-0.01 pts QoQ
FII
49.56%
-8.40 pts QoQ
DII (other)
1.69%
-0.01 pts QoQ
Mutual funds
14.18%
+8.16 pts QoQ
Retail & others
2.24%
+0.26 pts QoQ
Filed order
Promoters32.3%32.3%32.4%32.4%
FII49.6%58.0%57.9%58.1%
DII (other)1.7%1.7%2.0%2.0%
Mutual funds14.2%6.0%5.9%5.8%
Retail & others2.2%2.0%1.9%1.8%
Promoters — QoQ changepts, derived-0.0%-0.0%-0.0%—
FII — QoQ changepts, derived-8.4%0.0%-0.1%—
DII (other) — QoQ changepts, derived-0.0%-0.3%-0.0%—
Mutual funds — QoQ changepts, derived8.2%0.1%0.1%—
Retail & others — QoQ changepts, derived0.3%0.1%0.1%—
Totalderived100.0%100.0%100.0%100.0%

Values are percentages of total outstanding shares; QoQ rows are percentage-point moves.

09/Events

Corporate actions

Dividends, bonuses, splits and rights issues. Filter by type, sort by any date, and expand a row for the full event detail.

No corporate actions on record

10/Comparison

Peers & competitors

Competitor set priced live. Filter by sector, sort any column, and expand a peer for its business description.

Sector
APOLLOHOSPApollo Hospitals Enter. LHealthcare Services₹9,200.00+5.29%14.13 L₹1,32,139 Cr$14.68B
MAXHEALTHMAX Healthcare INS LtdHealthcare Services₹1,081.00+3.88%95.32 L₹1,05,080 Cr$11.68B
MANIPALHOSManipal Health Enterpri LHealthcare₹702.20+0.83%11.62 L₹92,366 Cr$10.26B
ASTERDMAster DM Quality Care LtdHealthcare Services₹779.30+5.41%26.66 L₹67,960 Cr$7.55B
FORTISFortis Healthcare LtdHealthcare Services₹825.00+1.87%22.88 L₹62,284 Cr$6.92B
MEDANTAGlobal Health LimitedHealthcare Services₹1,480.20+0.13%2.65 L₹39,829 Cr$4.43B
NHNarayana Hrudayalaya Ltd.Healthcare Services₹1,945.00+3.84%7.85 L₹39,757 Cr$4.42B
LALPATHLABDR. LAL Path Labs Ltd.Healthcare Services₹1,989.00+1.31%2.65 L₹33,680 Cr$3.74B
KIMSKrishna Inst Of MED SCI LHealthcare Services₹795.60+3.62%10.44 L₹33,483 Cr$3.72B
SYNGENESyngene International LtdDiversified₹451.70+3.28%25.58 L₹18,240 Cr$2.03B

Market cap is the sector-constituent figure reported per peer · Showing 1–10 of 10

1 / 1

11/Coverage

Company news

Articles published in the last seven days, paginated by the provider.

No news in the last seven days

Company news is available for a rolling one-week window.

Full annual line itemsRevenue, other income, expenses, tax, EPS
ShowHide
Filed order
Revenue2,0801,7111,3321,018
Other Income44464414
Total Revenue2,1251,7571,3761,031
Total Expenses1,8771,5941,236948
Profit Before Tax24916014184
Tax815046-20
Profit After Tax16811095103
EPS - Basic4.212.803.144.01
EPS - Diluted4.182.783.134.00

This breakdown is available annually, even when the summary above is quarterly. EPS rows are per share.